Bleeding Web - the bleeding information source

Therapy


	Please Select:

	Hemostatic Drug Info Interesting Links PDA Software Article Summaries Slide Shows Review Articles What's New Disclaimer

Search the site

	Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.

	Unexpected bleeding disorders: Algorithm for approach to therapy.

	Inhibitor antibodies to factor VIII and factor IX: management.

	New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate.